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Schwannoma is a benign tumor that arises from the sheath of myelinated nerve ﬁbers and may occur in any part of the
body. Osteogenesis in schwannoma is extremely rare and, to date, new bone formation in sinonasal schwannoma has not yet
been reported. Here, we describe the ﬁrst reported case of sinonasal schwannoma with new bone formation. The tumor was
successfully treated by endoscopic sinus surgery, and the patient showed no evidence of recurrence 24 months postoperatively.
Immunohistochemically, the tumor expressed bone morphogenic protein 4, indicating a possible role of this protein in the new
bone formation in schwannomas.
1.Introduction
Schwannoma, also known as neurilemoma, is a benign
tumor that arises from the sheath of myelinated nerve ﬁbers
and may occur in any part of the body. Schwannomas
most commonly occurs in the head and neck region
(approximately 25%–45% of cases) but rarely in the nose
and sinuses [1–3]. Osteogenesis in schwannoma is extremely
rare, and only a few cases of schwannoma with osteogenesis
in the internal auditory canal, lacrimal gland, spine, or other
soft tissues have been reported [4–9]. New bone formation
in nasal polyps has been demonstrated [10, 11], and bone
formation in sinonasal inverted papilloma has been reported
recently [12, 13]; however, to date, new bone formation
in sinonasal schwannoma has not been reported. Here, we
describe the ﬁrst reported case of sinonasal schwannoma
with new bone formation. The tumor was successfully
treated by endoscopic sinus surgery (ESS).
2.CaseReport
An 81-year-old woman presented with a left nasal tumor
that caused left nasal obstruction. Nasal endoscopy revealed
a pinkish smooth mass that ﬁlled the left nasal cavity.
Enhanced computed tomography (CT) showed an inhomo-
geneouslyenhancing massthatﬁlledtheleftnasalcavity. The
tumor grew expansively and showed marked osteogenesis
(Figure 1). A low-density lesion with metal-dense spots
in the left maxillary sinus, indicating mycetoma, was also
observed. Magnetic resonance imaging (MRI) showed a
nasal tumor in the left nasal cavity with a hypointense signal
on T1-weighted images, and a moderately hyperintense
signals on T2-weighted images (Figure 2). The signal of the
nasal tumor was distinctly diﬀerent from that of the left
maxillary sinus lesions. Biopsy of the tumor was performed,
and preoperative pathologic examination revealed schwan-
noma. No neurologic defects were observed preoperatively.
ESS, which was selected on the basis of the preoperative
radiologic ﬁndings, was performed under general anesthesia.
Broad attachment of the tumor was observed in the superior
nasal meatus and middle turbinate. Harmonic Scalpel, an
ultrasonic dissector coagulator, and a suction curette were
used to excise the mucosa with tumor involvement, along
with a margin of macroscopically normal mucosa. Many
olfactoryﬁberswereidentiﬁedandresectedwiththemucosa.
The anterior ethmoid nerve was also identiﬁed and resected.
Newlygeneratedbonetissuewassurroundedwiththetumor.
The tumor was thus successfully removed in one piece with




nasal cavity. A low-density lesion with metal-dense spots in the left maxillary sinus, indicating mycetoma, was also observed. Bone window
images ((c), (d)) also showed a new bone formation in the tumor. Black arrows indicate a new bone formation.
A
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Figure 2: Horizontal (a) and axial (b) magnetic resonance imaging (MRI) showed a nasal tumor in the left nasal cavity with a hypointense
signal on T1-weighted images, and a moderately hyperintense signals on T2-weighted images. This signal was diﬀe r e n tf r o mt h a to ft h el e f t




Figure 3: Macroscopic (a) and microscopic (x100 magniﬁcation) (b) features of the excised tumor. The spindle cells are arranged in a
patternless fashion, and new bone formation consisting of randomly organized trabeculae lined by osteoblasts was observed in the tumor.







Figure 4: Immunohistochemistry for bone morphogenic protein (BMP; x100 magniﬁcation). (a) BMP-2, (b) BMP-4, and (c) BMP-7. The
tumor cells stained positive for BMP-4 and negative for BMP-2 and BMP-7. ∗asterisk: bone tissue.
a fungus ball was completely cleared from the left maxillary
sinus. The operation was performed for 1 hour, and the
intraoperative blood loss was 20ml.
Histopathologically, a patternless proliferation of spindle
cells and new bone formation consisting of randomly
organized trabeculae lined by osteoblasts were observed
in the tumor (Figure 3(b)). Immunohistochemically, the
tumor cells stained strongly positive for S-100 proteins
and negative for smooth muscle actin, desmin, and Ki-
67. Thus, a deﬁnitive diagnosis of schwannoma with new
bone formation was established. To further investigate the
osteogenesis in the tumor, the expression of bone mor-
phogenic proteins (BMPs) was examined. Rabbit polyclonal
antibodies (Abs) against human BMP-2, BMP-4 (LifeSpan
BioSciences, Seattle, WA), and BMP-7 (AVIVA Systems
Biology, San Diego, CA) were used for the detection of BMP
expression in the tumor. Four-micrometer-thick paraﬃn
sections were prepared for light microscopic examination.
After incubation with Abs against BMPs, sections were
incubated with biotinylated antirabbit IgG (Vector Lab-
oratories, Burlingame, CA). After rinsing, sections were
incubated with ABC reagent (Vector Laboratories) and
developed in 0.05% 3,3 -diaminobenzidine-0.01% H2O2
substrate medium in 0.1M phosphate buﬀer. Interestingly,
the tumor cells stained positive for BMP-4 and negative for
BMP-2 and BMP-7 (Figure 4). Western blot analysis was
also performed to conﬁrm the expression of BMPs in the
tumor. The tumor tissue lysates were subjected to SDS-
PAGE.Afterelectrophoresis,proteinsweretransferredontoa
PVDF membrane (Millipore, Billerica, MA, USA). The blots
were incubated with Abs against BMP-2, -4, and -7, same
as immunohistochemistry. After washing, membranes were
incubated with HRP-conjugated goat anti-rabbit IgG sec-
ondary Ab (Santa Cruz Biotechnology, Inc.). Protein bands
were visualized with ECL substrate (GE Medical). The result
showed the expression of BMP-4, but not BMP-2 and -7, in
the similar manner to the result of immunohistochemistry
(Figure 5).
Histopathologic examination also showed aspergillosis
in the left maxillary sinus. The postoperative course was
uneventful with no complications or neurologic defects.
There was no recurrence at the 2-year followup examination.4 International Journal of Otolaryngology
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Figure 5: Western blot analysis for BMP. The tumor tissue expres-
sed BMP-4 but not BMP-2 and -7.
3. Discussion
Schwannoma commonly occurs in the head and neck
region but rarely in the nasal cavity and sinuses [1–3]. In
addition, new bone formation accompanying schwannoma
is extremely rare, with only a few cases of schwannoma
with calciﬁcation in the internal auditory canal, lacrimal
gland, spine, and other softtissues having been reported [4–
9]. To date, sinonasal schwannoma with new bone formation
has not been reported. Here, we present the ﬁrst case of
sinonasal schwannoma with new bone formation and its
clinical management.
There have been three reported cases of bone formation
in nasal polyps [10, 11]. In addition, four cases of the
association of inverted papillomas and new bone formation
have been reported recently [11, 12]. However, the mech-
anism of osteogenesis in these inﬂammatory and tumor
tissues remains unclear. Calciﬁcations may be classiﬁed as
entrapped bone structures or as primary tumoral calciﬁ-
cations. Essentially, entrapped bone is the bone fragment,
which is enclosed within the tumor and erodes due to
pressure atrophy whereas primary tumorous calciﬁcation is
calciﬁcation created by the tumor itself; both may appear as
calciﬁcations on CT [13]. The histopathologic examination
revealed no entrapped bone or primary tumor calciﬁcation
in the current bone structure. The examination showed new
bone formation consisting of randomly organized trabeculae
lined by osteoblasts. These randomly organized trabeculae
were divided with prominent capillaries and mesenchymal
cells. In general, however, the entrapped bone should be in a
lamellar structure, but in our case, the bone trabeculae were
woven and represented active osteoblast production of newly
formed bone. In addition, intraoperative ﬁndings showed
that the newly generated bone in the tumor was independent
of normal anatomical bone structure. Thus, the current case
was diagnosed as schwannoma with new bone formation.
Clinically, schwannoma with accompanying new bone
formation might appear to behave no diﬀerently from
commonschwannoma,anditsfeaturesmightbesimilar.The
treatment of choice for sinonasal schwannoma is surgery. To
date, less than 100 cases of sinonasal schwannoma have been
reported [1–3], and diﬀerent approaches, including lateral
rhinotomy with external ethmoidectomy, the Caldwell-Luc
approach, midfacial degloving, or ESS, have been employed
in relation to tumor extension [3, 14]. ESS is now widely
accepted and commonly performed in cases requiring nose
or paranasal sinus surgery. ESS provides excellent mag-
niﬁcation, illumination, and angled visualization, thereby
allowing the surgeon to isolate the base of the tumor and
accurately deﬁne the extent of disease. Long-term followup
of our patient will reveal the optimal clinical management of
sinonasal schwannoma with new bone formation.
Another important ﬁnding in this paper is the demon-
stration of BMP expression in the tumor. This is the ﬁrst
paper showing BMP expression in schwannomas. BMPs are
multifunctional growth factors belonging to transforming
growth factor beta superfamily. It has been demonstrated
that BMPs had been involved in the regulation of cell
proliferation, survival, diﬀerentiation, and apoptosis [15].
However, their hallmark ability is that play a pivotal role in
inducing bone, cartilage, ligament, and tendon formation
at both heterotopic and orthotopic sites. Extensive studies
demonstrate that BMPs are important factors regulating
chondrogenesis and skeletogenesis during normal embry-
onic development [16]. The BMPs with greatest osteogenic
capacity are BMP-2, -4, -5, -6, -7, and -9. BMP-2 acts as a
disulﬁde-linked homodimer and induces bone and cartilage
formation. It is candidate as a retinoid mediator and plays
a key role in osteoblast diﬀerentiation. BMP-4 regulates the
formation of teeth, limbs, and bone from mesoderm and
also plays a role in fracture repair. BMP-7 plays a key role in
osteoblast diﬀerentiation [15]. Expression of BMPs in tumor
tissues has also been reported [17]. BMP 2/4 was localized
predominantly to the cytoplasm of malignant cells with
primitive mesenchymal features; no or little BMP is detected
in the more diﬀerentiated elements of bone and softtissue
sarcomas [17]. Diﬀerent levels of BMP 2/4 expressions in
bone and soft tissue sarcomas have been considered to be
associated with the stage of mesenchymal diﬀerentiation.
In the current case, the schwannoma cells expressed BMP-
4 inhomogenously. Although the detail of role of BMP
remains unclear in the pathogenesis in the current tumor,
this indicates possible role of BMP-4 for new bone formation
in schwannomas.
In conclusion, we have described the ﬁrst reported case
of sinonasal schwannoma with new bone formation. ESS
couldbesuccessfullyusedtoachievecompleteremovalofthe
tumor. BMP-4 might be associated with new bone formation
in the tumor.
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